Albemarle (NYSE:ALB) Reaches New 52-Week Low – Here’s What Happened

Albemarle Corporation (NYSE:ALB – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday. The stock traded as low as $89.17 and last traded at $90.2320, with a volume of 205,734 shares trading hands. The stock had previously closed at $93.53.

Wall Street Analyst Weigh In

A number of analysts have issued reports on ALB shares. Rothschild & Co Redburn reduced their price target on Albemarle from $100.00 to $86.00 in a report on Wednesday, November 11th. Robert W. Baird lowered their price target on shares of Albemarle from $157.00 to $123.00 in a research report on Wednesday, October 14th. Truist Financial reissued a “buy” rating and issued a $170.00 price objective (down from $185.00) on shares of Albemarle in a report on Friday, November 6th. Wall Street Zen cut shares of Albemarle from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Finally, UBS Group cut their price objective on shares of Albemarle from $150.00 to $137.00 and set a “buy” rating for the company in a research report on Monday, November 9th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $152.63.

Check Out Our Latest Stock Analysis on ALB

Albemarle Price Performance

The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 2.34. The stock’s 50-day moving average is $103.61 and its two-hundred day moving average is $145.56. The stock has a market cap of $10.58 billion, a PE ratio of 21.65, a PEG ratio of 0.59 and a beta of 1.34.

Albemarle (NYSE:ALB – Get Free Report) last announced its earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.05. The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.52 billion. Albemarle had a return on equity of 14.91% and a net margin of 10.40%. The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.19) earnings per share. On average, equities analysts predict that Albemarle Corporation will post 10.64 earnings per share for the current year.

Albemarle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be given a dividend of $0.41 per share. This represents a $1.64 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Friday, December 18th. Albemarle’s dividend payout ratio (DPR) is currently 39.61%.

Institutional Investors Weigh In On Albemarle

Institutional investors have recently modified their holdings of the company. Primecap Management Co. CA purchased a new position in Albemarle during the 2nd quarter worth $358,101,000. ProShare Advisors LLC increased its stake in Albemarle by 69.7% in the third quarter. ProShare Advisors LLC now owns 1,436,117 shares of the specialty chemicals company’s stock valued at $151,912,000 after purchasing an additional 589,787 shares during the period. Deutsche Bank AG purchased a new stake in shares of Albemarle in the second quarter valued at about $131,049,000. Amundi raised its holdings in shares of Albemarle by 40.5% in the second quarter. Amundi now owns 827,874 shares of the specialty chemicals company’s stock valued at $111,784,000 after buying an additional 238,774 shares during the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Albemarle during the second quarter worth about $103,268,000. 92.87% of the stock is owned by institutional investors and hedge funds.

About Albemarle

(Get Free Report)

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.

Featured Stories

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.